Search

everythinglearnresearchcommunity

for

Search:↓

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

New and repurposed treatments are improving outcomes in dermatology.

Low-dose isotretinoin is effective for treating pediatric scarring alopecia.

Exosomes from stem cells can reduce UV-induced skin damage by lowering inflammation and oxidative stress.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.

Bimatoprost shows promise for treating vitiligo, especially when combined with other therapies.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Deleting Twist1 in skin cells reduces UVB-induced skin cancer risk.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Photobiomodulation therapy significantly increases hair density and growth for androgenic alopecia, but more research is needed to confirm safety.

Higher SPF sunscreens provide more DNA protection, and the form of sunscreen doesn't affect protection level.

A method was found to visualize hair regrowth and avoid unnecessary side effects from treatments.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

PRP combined with vitamin D improves vitiligo more effectively than vitamin D alone.

Both fixed and incremental laser treatments effectively reduced underarm hair, but the fixed method was less painful.

Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.

Riboflavin with blue light speeds up hair dyeing, making it faster, safer, and long-lasting with less hair damage.

The woman's widespread skin condition did not improve despite various treatments.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.